Maxime P. Look
Impact in
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Protease and Inhibitor Mechanisms 19
- Cancer Genomics and Diagnostics 10
- Breast Cancer Treatment Studies 10
- Oncology 26
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 6
- Co-authors
- John A. Foekens (82 shared papers)Anieta M. Sieuwerts (34 shared papers)Marion E. Meijer‐van Gelder (35 shared papers)Jan G.M. Klijn (26 shared papers)Mieke A. M. Timmermans (7 shared papers)Dmitri Talantov (2 shared papers)Jack X. Yu (2 shared papers)Fei Yang (2 shared papers)
- Journals
- Breast Cancer Research and Treatment (12 papers)British Journal of Cancer (10 papers)Journal of Clinical Oncology (6 papers)International Journal of Cancer (5 papers)Breast Cancer Research (4 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Maxime P. Look
113 papers receiving 11.0k citations
Maxime P. Look's Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 4.6k
- Oncology 3.3k
- Immunology and Allergy 603
- Molecular Biology 5.4k
- Genetics 1.1k
Countries citing papers authored by Maxime P. Look
This map shows the geographic impact of Maxime P. Look's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime P. Look with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime P. Look more than expected).
Fields of papers citing papers by Maxime P. Look
This network shows the impact of papers produced by Maxime P. Look. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime P. Look. The network helps show where Maxime P. Look may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime P. Look, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Hit paper breakdown → | 2005 | 2275 |
| 2 | Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Hit paper breakdown → | 2005 | 1026 |
| 3 | 2002 | 497 | |
| 4 | The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. | 2000 | 369 |
| 5 | 2008 | 328 | |
| 6 | 2005 | 283 | |
| 7 | High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. | 2001 | 267 |
| 8 | RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. | 2003 | 258 |
| 9 | Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. | 2000 | 173 |
| 10 | 1998 | 171 | |
| 11 | Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). | 2002 | 162 |
| 12 | Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. | 1995 | 161 |
| 13 | 2013 | 160 | |
| 14 | 1995 | 150 | |
| 15 | 2007 | 150 | |
| 16 | 2008 | 143 | |
| 17 | 1998 | 137 | |
| 18 | 2017 | 132 | |
| 19 | 1996 | 131 | |
| 20 | 1997 | 131 |
About Maxime P. Look
Maxime P. Look is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Molecular Biology and Genetics, having authored 114 papers that have together received 11.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (19 papers), Cancer Genomics and Diagnostics (10 papers), Breast Cancer Treatment Studies (10 papers), Cell Adhesion Molecules Research (10 papers), Estrogen and related hormone effects (8 papers), HER2/EGFR in Cancer Research (8 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Cancer Research (4.6k citations), Oncology (3.3k citations), Immunology and Allergy (603 citations), Molecular Biology (5.4k citations) and Genetics (1.1k citations). Maxime P. Look has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include John A. Foekens, Anieta M. Sieuwerts, Marion E. Meijer‐van Gelder, Jan G.M. Klijn, Mieke A. M. Timmermans, Dmitri Talantov, Jack X. Yu, Fei Yang, Els M.J.J. Berns and J.G.M. Klijn. Their work appears in journals such as Breast Cancer Research and Treatment, British Journal of Cancer, Journal of Clinical Oncology, International Journal of Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.